|

Drug
Patent Expirations in March 2008
Applicant :: TRADENAME :: generic name
Ucb Inc :: SEMPREX-D :: acrivastine; pseudoephedrine
hydrochloride
Bayer Pharms :: CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER :: ciprofloxacin
Bayer Pharms :: CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER ::
ciprofloxacin
Biovail :: CARDIZEM CD :: diltiazem hydrochloride
Pfizer :: CARDURA XL :: doxazosin mesylate
Astrazeneca :: NEXIUM :: esomeprazole magnesium
Women First Hlthcare :: ESCLIM :: estradiol
Novartis :: VIVELLE :: estradiol
Bristol Myers Squibb :: IFEX :: ifosfamide
Bristol Myers Squibb :: IFEX/MESNEX KIT :: ifosfamide; mesna
Therakos :: UVADEX :: methoxsalen
Astrazeneca :: TOPROL-XL :: metoprolol succinate
Barrier :: VUSION :: miconazole nitrate; petrolatum, white; zinc oxide
R Tech Ueno Ltd :: RESCULA :: unoprostone isopropyl
This list does not discriminate between dominant and non-dominant patents.
Listed drugs above may be protected by additional patents and other regulatory
protections.
For more details, visit DrugPatentWatch at
http://www.DrugPatentWatch.com
To subscribe to the free Patent Expiration Bulletin,
visit
http://www.DrugPatentWatch.com/newsletter
Disclaimer:
All trademarks and applicant names are the property of their respective owners
or licensors. Drug patent expiration data is presented "as is." Use of this
information is at your own risk. No warranty is expressed or implied. There is
no warranty that the drug patent expriation information is error free.
---
ABOUT DrugPatentWatch (
http://www.DrugPatentWatch.com )
DrugPatentWatch provides information on drug patent
expirations. Complete details are provided for all FDA-approved small molecule
drugs. Sales information is available for top-selling drugs. This value-added
information supports the critical business functions of patent agents and
attorneys, pharmaceutical companies, wholesalers, healthcare payers, and
investors.
|